Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXAS | ROIV | INCY | ||
| Company | Exact Sciences Cor | Roivant Sciences Ltd | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 104.93 | 30.30 | 97.75 | ||
| High | 104.98 | 30.42 | 98.00 | ||
| Low | 104.90 | 29.65 | 96.23 | ||
| Latest | 104.91 | 29.99 | 96.74 | ||
| Change | +0.99 | +0.11 | -0.76 | ||
| % Change | +0.95% | +0.37% | -0.78% | ||
| Volume | 21,562,100 | 7,734,900 | 2,902,900 | ||
| 20-Day Average Volume | 3,124,595 | 6,668,860 | 1,271,890 | ||
| Previous Close | 103.92 | 29.88 | 97.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 103.57 | 29.28 | 97.50 | ||
| 20-Day Raw Stochastic | 96.55% | 46.85% | 29.63% | ||
| 20-Day Relative Strength | 75.93 | 54.80 | 49.48 | ||
| Weighted Alpha | +85.47 | +162.36 | +36.61 | ||
| Today's Opinion | 100% Buy | 100% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 64% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 03/13/26 | -2.88% since 05/21/26 | -0.69% since 05/21/26 | ||
| Low | 103.60 on 03/16/26 | 29.03 on 05/27/26 | 96.04 on 05/22/26 | ||
| High | 104.98 on 03/20/26 | 30.86 on 05/22/26 | 98.85 on 05/27/26 | ||
| 1-Month | |||||
| %Chg | +1.43% since 02/20/26 | +8.98% since 04/29/26 | -2.38% since 04/29/26 | ||
| Low | 102.95 on 02/27/26 | 27.52 on 05/04/26 | 94.10 on 05/19/26 | ||
| High | 104.98 on 03/20/26 | 32.79 on 05/20/26 | 103.01 on 05/11/26 | ||
| 3-Month | |||||
| %Chg | +3.03% since 12/19/25 | +3.63% since 02/27/26 | -4.47% since 02/27/26 | ||
| Low | 101.44 on 12/23/25 | 25.95 on 03/30/26 | 89.25 on 03/24/26 | ||
| High | 104.98 on 03/20/26 | 32.79 on 05/20/26 | 103.01 on 05/11/26 | ||
| 6-Month | |||||
| %Chg | +96.76% since 09/19/25 | +44.11% since 11/28/25 | -7.39% since 11/28/25 | ||
| Low | 51.75 on 09/24/25 | 19.96 on 12/02/25 | 89.25 on 03/24/26 | ||
| High | 104.98 on 03/20/26 | 32.79 on 05/20/26 | 112.29 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,026,062 | 21,385,144 | 19,478,744 | ||
| Shares Outstanding, K | 190,888 | 715,701 | 199,782 | ||
| Annual Sales | 3,246,990,000 | 8,260,000 | 5,141,240,000 | ||
| Annual Net Income | -207,950,000 | -299,770,000 | 1,286,650,000 | ||
| Last Quarter Sales | 878,380,000 | 2,520,000 | 1,272,680,000 | ||
| Last Quarter Net Income | -85,960,000 | 302,990,000 | 303,330,000 | ||
| 60-Month Beta | 1.41 | 1.14 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 02/13/26 | -0.36 on 05/20/26 | 1.81 on 04/28/26 | ||
| Earnings Date | 05/07/26 | 08/10/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 2,598.00 | 0.00 | 15.09 | ||